TESTING
TREATMENTS - BETTER RESEARCH
FOR BETTER HEALTHCARE
By Imogen
Evans, Hazel Thornton, and Iain Chalmers
REFERENCES 91-115
91 Angell M. Is academic medicine for sale? New England Journal of
Medicine
2000;342:1516–8.
92 Grant J, Green L, Mason B. From bench to bedside: Comroe and Dripps
revisited.
HERG Research Report No. 30. Uxbridge, Middlesex: Brunel University
Health
Economics Research Group, 2003.
93 Pound P, Ebrahim S, Sandercock P, et al. Reviewing Animal Trials
Systematically
(RATS) Group. Where is the evidence that animal research benefits
humans? British
Medical Journal 2004;328:514–7.
94 Jones S. Genetics in medicine: real promises, unreal expectations
[Milbank report]. New York: Milbank Memorial Fund, 2000. Available
from: www.milbank.org [accessed 12 December 2005].
95 Mackillop WJ, Palmer MJ, O’Sullivan B, et al. Clinical trials in
cancer: the role of
surrogate patients in defining what constitutes an ethically acceptable
clinical
experiment. British Journal of Cancer 1989;59:388–95.
96 Jobling R. Therapeutic research into psoriasis: patients’
perspectives, priorities and
interests. In: Rawlins M, Littlejohns P, ed. Delivering quality in the
NHS 2005.
Abingdon: Radcliffe Publishing Ltd, pp53–6.
97 Dixon-Woods M. Agarwak S, Jones J, et al. Synthesising qualitative
and quantitative
evidence: a review of possible methods. Journal of Health Services
Research and Policy
2005;10:45–53.
98 Koops L, Lindley RI. Thrombolysis for acute ischaemic stroke:
consumer
involvement in design of new randomised controlled trial. British
Medical Journal
2002;325:415–7.
99 Donovan J, Mills N, Smith M, et al. Quality improvement report:
improving design
and conduct of randomised trials by embedding them in qualitative
research:
ProtecT (prostate testing for cancer and treatment) study. British
Medical Journal
2002;325:766–9.
100 Edwards A, Elwyn G, Atwell C, et al. Shared decision making and
risk communication in general practice – a study incorporating
systematic literature reviews, psychometric evaluation of outcome
measures, and quantitative, qualitative and health economic analyses of
a cluster randomised trial of professional skill development. Report to
‘Health in Partnership’ programme, UK Department of Health. Cardiff:
Department of General Practice, University of Wales College of
Medicine, 2002.
101 Longo M, Cohen D, Hood K, et al. Involving patients in primary care
consultations:
assessing preferences using Discrete Choice Experiments. British
Journal of General Practice 2006;56:35–42.
102 Marsden J, Bradburn J. Patient and clinician collaboration in the
design of a national randomised breast cancer trial. Health
Expectations 2004;7:6–17.
103 Warlow C, Sandercock P, Dennis M, Wardlaw J. Research funding.
Lancet 1999;353:1626.
104 Chalmers I, Rounding C, Lock K. Descriptive survey of
non-commercial randomised
trials in the United Kingdom, 1980–2002. British Medical Journal
2003;327:1017–9.
105 Relman AS. Publications and promotions for the clinical
investigator. Clinical
Pharmacology and Therapeutics 1979;25:673–6.
106 Warlow C. Building trial capacity (in a hostile environment). Paper
presented at
Clinical Excellence 2004, Birmingham, 30 November 2004.
107 Eclampsia Trial Collaborative Group. Which anticonvulsant for women
with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet
1995;345: 1455–63.
108 Alderson P, Roberts I. Corticosteroids for acute traumatic brain
injury. The Cochrane
Database of Systematic Reviews 2005, Issue 1. Art. No.: CD000196.
Available from:
www.thecochranelibrary.com [accessed 3 January 2006].
109 Roberts I, Yates D, Sandercock P, et al; CRASH trial collaborators.
Effect of intravenous corticosteroids on death within 14 days in 10 008
adults with clinically significant head injury (MRC CRASH trial):
randomised placebo-controlled trial. Lancet 2004;364:1321–8.
110 House of Commons Health Committee. The influence of the
pharmaceutical industry. Fourth Report of Session 2004–2005. London:
Stationery Office, 2005. Available from:
www.publications.parliament.uk/pa/cm200405/cmselect/ cmhealth/42/42.pdf
[accessed 1 January 2006].
111 MRC announces plans for strengthening UK clinical research. MRC
Network,
Summer 2005.
112 Department of Health. Best research for best health: a new national
health research
strategy. London: Stationery Office, 2006. Available from
www.dh.gov.uk/research
113 Cochrane Injuries Group Albumin Reviewers. Human albumin
administration in critically ill patients: systematic review of
randomised controlled trials. British Medical Journal 1998;317:235–40.
114 Finfer S, Bellomo R, Bryce N, et al (SAFE Study Investigators). A
comparison of albumin and saline for fluid resuscitation in the
intensive care unit. New England Journal of Medicine 2004;350:2247–56.
115 Tallon D, Chard J, Dieppe P. Relation between agendas of the
research community and the research consumer. Lancet 2000;355:2037–40.
|
